Vidhi Specialty Food Ingredients Ltd (VIDHIING) Q2FY27 Concall Summary - Sep-2026 Qtr
Key Takeaways
- A new capex of Rs. 75-85 crores at Dahej is planned, targeting Rs. 225-250 crores in annual revenue from a new value-added product line by FY28.
- The 'CoatIcon' pharmaceutical coatings division will see a dedicated capex of Rs. 25-35 crores, with significant revenue ramp-up expected in 2-3 years after lengthy approvals.
- Management confirmed H2 FY27 performance is expected to be similar or slightly better than H1, supported by a strong order book and improving product mix.
Performance Overview
- The company delivered a strong performance with revenue growth of 82% year-over-year, driven by both manufacturing and opportunistic trading sales.
- Profitability improved significantly, with EBITDA growing 49.2% and PAT increasing by 66.9% compared to the same quarter last year.
- The company is successfully navigating a challenging geopolitical environment, particularly in the Middle East and Europe, which has led to increased freight and raw material costs.
- Strategic initiatives are progressing well, with the Dahej expansion on track and the new 'CoatIcon' pharmaceutical coating business gaining initial traction.
- Management highlighted a strong order book, suggesting that the growth momentum seen in the first half is expected to continue or slightly improve in the second half of the fiscal year.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.